Editorial
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 7, 2011; 17(9): 1095-1108
Published online Mar 7, 2011. doi: 10.3748/wjg.v17.i9.1095
Table 1 Factors involved in glucocorticoid resistance
GRReduced GR mRNA expression[42]
Reduced GC binding affinity[43]
Polymorphisms in the NR3C1 gene[45]
GR heterocomplexAltered expression of the chaperones and co-chaperones that make up the heterocomplex[74-78]
Polymorphisms in the Hsp90 gene[79]
Genetic variations in the STIP1 gene coding for Hop[79]
Nuclear transport factorsPolymorphisms in the Importin 13 gene[86]
Transcription machineryLower expression of SMARCB1 in resistant leukaemia cells[97]
Pro-inflammatory mediatorsPolymorphisms in the NALP1 gene[72]
TNF-α promoter SNP correlated with steroid response in several disease[149-154]
IL-10 polymorphisms related with a positive prednisone response in children with ALL[159]
P-gpHyperexpression of P-gp in lymphocytes and epithelial cells from GC-resistant IBD patients[167]
Table 2 Factors involved in glucocorticoid resistance in inflammatory bowel disease
GRSignificantly lower expression of GR mRNA in the intestinal mucosa in patients with GC-resistant IBD[42]
In colonic biopsies of UC patients, significantly more GRβ positive cells in the resistant group than in the GC sensitive control group[60]
Significantly higher frequency of BclI polymorphism in GC-responsive IBD patients[61]
Pro-inflammatory mediatorsTNF-α G-308A polymorphism significantly associated with steroid resistance and requirement for surgery[152]
Association between this polymorphism and steroid dependency in a large population of CD patients[155]
Higher probability of non-response to GCs in pediatric IBD patients carriers of the NALP1 variant genotype[72]
P-gpHyperexpression of P-gp in circulating lymphocytes and epithelial cells from patients with GC resistant IBD[167]
Association between GC refractory CD and P-gp intronic polymorphisms[173]
C3435T polymorphism in pediatric IBD Italian patients treated with GC not associated with response to therapy[152]